<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:department>Inst of Pharmacy and Biomedical Sci</gtr:department><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B1DC9C94-1C94-447A-9DB2-D49D1A5C2DFC"><gtr:id>B1DC9C94-1C94-447A-9DB2-D49D1A5C2DFC</gtr:id><gtr:firstName>Owain</gtr:firstName><gtr:otherNames>Richard</gtr:otherNames><gtr:surname>Millington</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=NC%2FM000648%2F1"><gtr:id>71A62CB7-0A7E-4FDA-A5FB-A59634CF9DF2</gtr:id><gtr:title>Refining the mouse model of footpad immunisation and infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>NC/M000648/1</gtr:grantReference><gtr:abstractText>Research into understanding the immune response to vaccination and infectious disease often necessitates the use of animal models due to the complexity of the cellular interactions involved. Often, researchers have used the mouse rear footpad as a convenient site of immunisation or infection because this site is readily accessible for measuring inflammation and because the physiology of the site has been well-characterised. However, mice are predominantly weight-bearing in their rear feet and swelling in the footpad can be associated with lameness and discomfort. We plan to test whether injecting mice on the top of the rear foot represents a simple, scientifically-valid REFINEMENT to such animal tests. We will first characterise whether the induction of immune responses differ between these two sites before testing the potential of this site for parasite infection. Importantly, we will quantify the impact of this refinement by measuring any reduction in animal lameness and pain throughout infection. Together, these data will allow us to quantify any improvement in animal welfare, as well as to provide scientific validation for using this alternative model of infection.</gtr:abstractText><gtr:technicalSummary>Our aim is to REFINE the 'traditional' model of footpad immunisation and infection in order to improve animal welfare. We will use a combination of immunological and cutting-edge imaging methods to define the key parameters associated with the administration of antigens, cells or parasites in the dorsal aspect to the foot, comparing it to the established footpad model. We will also assess development of Leishmania infection at this alternative site to establish whether parasite growth and ease of monitoring lesion development are comparable. Critically, we will use a combination of methods to assess any improvement in animal welfare in order to determine whether our proposal truly represents a refinement to currently used methods.</gtr:technicalSummary><gtr:fund><gtr:end>2016-02-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/66BB3CDB-84B4-41B5-AB21-FEC312E91CC8"><gtr:id>66BB3CDB-84B4-41B5-AB21-FEC312E91CC8</gtr:id><gtr:name>NC3Rs</gtr:name></gtr:funder><gtr:start>2014-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>72442</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">NC/M000648/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>